Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Sanofi (SASY.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-03-30	93.58	122.00	Buy
2022-04-08	104.46	121.00	Buy
2022-05-04	99.72	120.00	Buy
2022-06-02	99.33	118.00	Buy
2022-06-06	100.16	119.00	Buy
2022-06-30	96.34	118.00	Buy
2022-08-09	95.48	103.00	Neutral
2022-11-21	87.18	92.00	Neutral
2022-12-14	90.02	97.00	Neutral
2023-01-09	90.44	93.00	Neutral
2023-03-30	99.43	100.00	Neutral
2024-01-15	94.36	110.00	Buy
2025-01-17	98.19	115.00	Buy
2025-01-31	104.40	120.00	Buy
2025-04-25	92.36	115.00	Buy

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.